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Abstract
Background. Immunosuppression at the feto-maternal interface is crucial for a successful pregnancy 
outcome. Human leukocyte antigen-G (HLA-G) seems to be a major contributor to fetal tolerance. The HLA-G 
expression is seen in cytotrophoblasts and in maternal blood. Fetal HLA-G acts on decidual antigen-presenting 
cells (APCs), natural killers (NKs) and T cells. Recent findings revealed that defects in placentation and their 
consequences are associated with maternal HLA-G variants and their expression levels.
Objectives. The objective of this article is to investigate the relationship between fetal HLA-G alleles and 
miscarriage, which has not been investigated to date.
Material and methods. The present study includes 204 recurrent miscarriage (RM) cases who were admit-
ted to our clinic between 2012 and 2016. Twenty-eight miscarriage products without maternal cell contami-
nation and any known pathology were analyzed by HLA-G typing. In addition, 3’ untranslated region (UTR) 
14-base pair (bp) insertion/deletion polymorphism was also investigated by Sanger sequencing.
Results. For our population, the most frequent HLA-G type was G*01:01, both in the study group (30.3%) 
and in the control group (47%). The study revealed that the G*01:04 allele was significantly associated with 
miscarriage (p = 0.007). The 3’ UTR 14bp deletion was more frequent in the miscarriage group, but there 
was no significant correlation.
Conclusions. HLA-G alleles seem to be related with miscarriage and should be considered in RM cases.
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Introduction
Human leukocyte antigen-G (HLA-G) is an atypical HLA 
(Class Ib) molecule and is mainly expressed in immune-
privileged sites of the body. There are accumulating re-
ports on the possible involvement of HLA-G in cancer, 
transplantation, allergies, and autoimmune disorders.1–3 
The role of HLA-G in the maintenance of maternal toler-
ance and in reproduction has been also widely studied.4 
Up to 50% of the endometrium of a pregnant uterus (de-
cidua) is composed of maternal immune cells.5 The mother 
is expected to generate graft-attacking antibodies and a cy-
totoxic T lymphocyte response to foreign paternal HLA 
or other antigens expressed by the fetal cells.1 Ensuring 
immune tolerance to the semi-allogenic fetus is achieved 
by the immune modulation of decidual natural killer (NK) 
cells, antigen presenting cells (APCs), including dendrit-
ic cells and macrophages (innate immune system), and 
by regulatory T cells (adaptive immune system). Shal-
low fetal trophoblast invasion is likely related to a partial 
breakdown of maternal–fetal immune tolerance and may 
underlie recurrent miscarriage (RM) and preeclampsia.5,6
Trophoblasts strictly regulate their expression of HLA 
genes. HLA Class Ia (A, B and C) are not expressed by tro-
phoblasts to prevent a maternal immune response – the 
exception is the mild expression of HLA-C. A special set 
of HLA Class (Ib: E, F and G) is presented on the fetal 
cells, which are thought to have an inhibitory effect on the 
maternal immune system.1 These molecules share struc-
tural similarities with Class Ia antigens, but also have 
some distinct features. In contrast to Ia antigens, Class 
Ib antigens are not ubiquitous. Their expressions are 
organ-specific and conditional. Atypical Class Ib anti-
gens have a low number of alleles and have both soluble 
and membrane-bound forms. On the other hand, typical 
Class Ia antigens are highly polymorphic and only have 
membrane-bound forms.7
The expression of HLA-G was first described in the pla-
centa as the conventional β2m-linked, membrane-bound 
form. However, studies reveal that HLA-G has 7 splice 
variants, including 4 membrane-bound (HLA-G1 to -G4) 
and 3 soluble isoforms (HLA-G5 to -G7). Furthermore, 
membrane-bound HLA-G1 can be shed and released as 
soluble HLA-G1. About 50 HLA-G alleles and 16 proteins 
have been reported to date.8
HLA-G has 7 introns and 8 exons. Exon 1 is  related 
to a signal peptide. Exons 2, 3 and 4 encode the extracellu-
lar domains: α1, α2 and α3, respectively. Intron 4 contains 
a stop sequence and yields soluble G5 and G6 isoforms. 
The transmembrane domain is encoded by exon 5. Exons 
6 and 7 encode the intracellular domain.
The polymorphisms of HLA-G have also been widely 
studied.1,4,8–12 The HLA-G gene has 14-base pair (bp) in-
sertion/deletion (ins/del) polymorphism in 3’ untranslated 
region (UTR), which influences messenger RNA (mRNA) 
size and stability.1 An inserted 14bp sequence probably 
acts as a cryptic splice site and causes a 92bp deletion in 3’ 
UTR. As a result, HLA-G mRNA stability is increased.1,8
Recent studies have focused on the functions of HLA-G 
isoforms,3 HLA-G dimers and β2-microglobulin (β2m) asso-
ciation.13,14 The disulfide-linked homodimer of β2m-asso- 
ciated HLA-G is found to be the major fraction expressed 
by trophoblast cells.15 LIRB1 has been proposed as the 
principal ligand for the HLA-G dimer, which is expressed 
on decidual APCs, NKs and T lymphocytes. Interactions 
with LIRB2, CD160, KIR2DL4, and other receptors have 
also been reported.15–17
HLA-G alleles have been investigated in women with 
a history of miscarriage and in their partners, but not 
in conceptus material to date. One of the reasons for that 
is the difficulty in obtaining maternal-cell-free fetal tis-
sues and the increased failure rates for cell culture and 
polymerase chain reaction (PCR). In addition to these fac-
tors, many of the miscarriage samples contain chromo-
somal anomalies which should be excluded from the study 
groups. The determination of parental HLA-G alleles, as 
in the current literature, just leads to indirect estimations 
about the fetal HLA-G status. Definite fetal HLA-G geno-
typing should be the preferred approach instead of paren-
tal genotyping, because HLA-G is expressed by fetal tro-
phoblasts.15 In this study, we aimed to find an association 
between fetal HLA-G type, HLA-G 3’ UTR 14bp ins/del 
polymorphism and miscarriage, and to determine the most 
common HLA-G alleles in our population.18
Material and methods
Study and control groups
The study group consisted of 28 cases out of 204 patients 
referred to our center between 2012 and 2016 who had 
at least 2 miscarriages (range: 2–4). All of the mothers 
were investigated for hereditary thrombophilia. Miscar-
riage samples were karyotyped and analyzed by quantita-
tive fluorescent polymerase chain reaction (QF-PCR) for 
aneuploidies of chromosomes 13, 15, 16, 18, 21, and 22, 
and sex chromosomes. The short tandem repeat (STR) 
markers of a QF-PCR kit were also used to detect maternal 
cell contamination. At least 10 informative STR mark-
ers were needed to exclude maternal cell contamination. 
The samples with 46,XY karyotype or 46,XX karyotype 
with no maternal contamination were included. Miscar-
riage materials with chromosomal anomalies, culture 
failure or PCR failure were excluded. The mothers with 
thrombophilic mutations, a history of in vitro fertilization 
(IVF) or any known obstetric reason for miscarriage, such 
as uterine malformations, antiphospholipid syndrome or 
hormone disorders, were also excluded. Fetuses with an-
encephaly, increased nuchal translucency, anhydramnios, 
early rupture of membranes, or other major malformations 
on fetal ultrasonography were excluded. The mean age 
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of mothers was 30.3 years and the majority of pregnancy 
losses occurred during the 1st trimester (gestational weeks 
5–15). Twenty-one healthy individuals representing suc-
cessful deliveries were used as controls for HLA-G types 
determined by the sequencing of exons 2, 3 and 4. For 
3’ UTR polymorphism, 101 healthy individuals were used 
as controls. The project received the permission of the local 
Tepecik Training and Research Hospital ethics committee.
Routine genetic workup of miscarriage
The routine genetic investigation of miscarriage cases 
included a conventional cytogenetic analysis of the miscar-
riage sample by GTG banding (550 bands) and a QF-PCR 
analysis with 26 STR markers (Compact v3 QF-PCR; 
Devyser, Stockholm, Sweden). Hereditary thrombophilia 
mutations (Factor V Leiden and Factor II G20210A) were 
investigated by real-time PCR (FV R2 [H1299R] QLP 3.0; 
Prothrombin QLP 3.0, Iontek, Istanbul, Turkey) from ma-
ternal blood.
HLA-G typing
Exons 2, 3 and 4 were sequenced for HLA-G typing. 
Commercial primer/oligonucleotide sets dedicated for 
high-resolution HLA sequencing-based typing (SBT) for 
the identification of  HLA alleles were used according 
to the manufacturer’s protocols (SBTexcellerator® HLA 
Kits; GenDx, Utrecht, the Netherlands).
HLA-G 3’ UTR 14bp ins/del polymorphism 
(rs371194629)
The polymorphism was investigated by Sanger sequenc-
ing. The PCR primers were F: 5’-TGT GAA ACA GCT GCC 
CTG TGT-3’ and R: 5’-GTC TTC CAT TTA TTT TGT-3’. 
The PCR conditions were as follows: the first denaturation 
was at 95°C for 10 min; 35 cycles of denaturation at 95°C for 
30 s, annealing at 60°C for 45 s, and elongation at 72°C for 
45 s; and the last elongation was at 72°C for 7 min. The PCR 
products were purified as follows: 5 µL of PCR products 
were treated with 2 µL of ExoSAP-IT enzyme (USB; Af-
fymetrix, Santa Clara, USA) at 37°C for 30 min and at 
85°C for 15 min. Sequence PCR (cycle sequencing) was 
done using a reverse PCR primer (5 pmol) and a BigDye® 
Terminator v. 3.1 Cycle Sequencing Kit (Lifetechnologies, 
Waltham, USA). The sequence PCR conditions were as 
follows: at 96°C for 10 s, at 50°C for 5 s and at 60°C for 
4 min; the cycle was repeated 25 times. The products of se-
quence PCR were purified (the 2nd purification) by spin 
colon (ZR DNA Sequencing Clean-up Kit™, Zymo Re-
search, Irvine, USA). Sanger sequencing was performed 
by capillary electrophoresis after 5 min of denaturation 
(3500 Genetic Analyzer; Lifetechnologies). The obtained 
sequences were analyzed using SeqScape® software v. 3.0 
(Applied Biosystems by Life Technologies, Carlsbad, USA).
Statistical analysis
Allelic and genotypic frequencies were determined from 
the observed genotype counts, and the expectations of the 
Hardy-Weinberg equilibrium were evaluated by χ2 analysis. 
The χ2 test was used for comparisons between allelic and 
genotypic frequencies. Statistical analysis was done using 
SPSS v. 13 statistical software (SPSS Inc., Chicago, USA). 
A p-value <0.05 was considered statistically significant.
Results
In all groups, there were 10 HLA-G types, coded for 
4 distinct proteins, and their combinations gave rise to  
8 distinct genotypes. The most frequent HLA-G type was 
G*01:01 both in the study group (30.3%) and in the con-
trol group (47%). The findings are summarized in Table 1. 
G*01:01/*01:01 was the most frequent genotype for the 
study and control groups: its frequency was 35.7% in the 
study group and 48% among the controls. The genotypes 
G*01:04/*01:04, G*01:03/*01:04 and G*01:03/*01:06 were 
found only in the study group, and the G*01:06/*01:06 
genotype was found only in the control group (Table 2). 
There was a significant association between the HLA-G 
allele G*01:04 and miscarriage (p = 0.007).
The  results of  3’ UTR polymorphism are presented 
in Table 3. The frequency distribution of alleles was in Har-
dy-Weinberg equilibrium. In the miscarriage samples, the 
most frequent allele was the 14bp deletion (57%) and the 
most frequent genotype was homozygous deletion (39%). 
Homozygous deletion was approx. 2 times more frequent 
Table 1. Comparison of study and control groups’ HLA-G types
HLA-G types*
Frequencies 
in miscarriage 
samples, % (n)
Frequencies 
in control 
samples, % (n)
p-value
01:01 30.3 (17/56) 47 (19/42)
0.189
01:01:01 12.5 (7/56) 17.5 (7/42)
01:01:02 7.1 (4/56) 5 (2/42)
01:01:03 3.5 (2/56) 2.5 (1/42)
01:01:12 1.7 (1/56) –
01:06 7.15 (4/56) 22.5 (9/42) 0.176
01:03 7.15 (4/56) 5 (2/42) 0.299
01:04:01 12.5 (7/56) 5 (2/42)
0.007**01:04:04 12.5 (7/56) –
01:04 5.3 (3/56) –
The study group consisted of 28 miscarriage samples (56 alleles) and 
the control group included 21 blood samples (42 alleles) from healthy 
individuals. There were 10 HLA-G types that code 4 proteins. * The HLA-G 
types with the same initial 2 digits have the same amino acid (aa) 
sequence, e.g., 01:04:01 and 01:04:04 code for the same specific protein;  
** statistically significant.
For HLA nomenclature, see http://hla.alleles.org/nomenclature/naming.html.
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in the miscarriage group than in the controls. In the con-
trol group, the most frequent allele was the allele with 
insertion (54%), and heterozygosity was the most frequent 
genotype (53%).
Discussion
The  β2m-associated/free HLA-G dimers are shown 
to be expressed from trophoblasts.13,14 HLA-G stimulates 
trophoblastic invasion.3 In addition to this, it is one of the 
major tolerogenic molecules in pregnancy.1,2 The HLA-G 
expression is studied in preeclampsia, recurrent miscar-
riage and IVF.8 The results indicated an association between 
an HLA-G expression pattern and a risk of RM as well as 
other disorders.7
We proposed that the fetal HLA-G alleles may underlie 
miscarriage and that the condition may recur, so we could 
find the miscarriage-prone HLA-G alleles in the conceptus 
material of mothers with a history of miscarriage. Healthy 
adults were used as controls and they were assumed not 
to carry miscarriage-prone alleles. We investigated samples 
of 204 miscarriage cases that had at least 1 previous miscar-
riage. Triploidy (9 cases), trisomy 15 (8 cases), trisomy 16 
(6 cases), and 45,X (5 cases) were the leading causes of mis-
carriage in our series, and all cases with genetic pathol-
ogy were excluded from the study. Twenty-eight out of 204 
samples from distinct mothers constituted our study group.
There were 10 HLA-G types coded for 4 specific proteins 
(Table 1) and 8 genotypes were determined in all groups 
(Table 2). The G*01:04 allele was found in a homozygous 
state in 4 cases of the study group (14.3%) and in none 
of the controls. There was a significant correlation between 
the fetal HLA-G allele G*01:04 and miscarriage (p = 0.007). 
As an interesting point, all the samples with the G*01:04 
allele also had the 14bp deletion allele. The G*01:04 allele 
may be linked with the 14bp deletion and had to be inves-
tigated in our population.
Ober et al. showed that a variation in the parental HLA-G 
promoter influences miscarriage rates. They hypothesized 
that the transmission of a high-risk allele from either par-
ent to the fetus would be associated with fetal loss.10 Ma-
ternal homozygosity for 14bp insertion polymorphism has 
been proposed to predispose to miscarriage.11 We found 
that the allele with the 3’ UTR 14bp deletion polymorphism 
was the most frequent allele in the study group (57%). 
The homozygous genotype of the same allele was about 
2 times more common in the study group than in the con-
trols (39% vs 20%). The HLA-G allele with insertion was 
the most frequent (54%) in the control group (Table 3). 
The 14bp deletion of 3’ UTR seems to be related with mis-
carriage, but the restricted number of study group subjects 
(n = 28) unfortunately prevented any statistical association 
to be revealed.
In conclusion, fetal G*01:04 HLA-G type and the 3’ UTR 
14bp deletion polymorphism may underlie miscarriages, 
and investigations of HLA-G alleles with a larger sample 
of miscarriage products and related immune components 
(such as LIRB1 and NKs) may contribute to a better un-
derstanding of the miscarriage process.
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